Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:27:40.039Z.
Calculation as of: 2026-10-06T18:27:40.039Z.
Quote observation: 2026-10-06T18:25:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7cda135bbdc40ab96f6f5c38083b7dd78a9f140dcd8a254691991f8eaa2b9dc4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-10-20.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Neuphoria Therapeutics Inc.
Market Cap
$18.73M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.79M
EV/EBITDA Ratio
N/A
TTM Avg
47.55x
3Y Avg
64.91x
5Y Avg
64.91x
Market Cap
$17.99M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.14M
EV/EBITDA Ratio
N/A
TTM Avg
197.20x
3Y Avg
1380.98x
5Y Avg
1380.98x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | $18.73M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $18.80M | N/A | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $18.58M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.79M | N/A | 47.55x | 64.91x | 64.91x |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | N/A | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $17.68M | N/A | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $20.16M | N/A | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | N/A | 197.20x | 1380.98x | 1380.98x |
| Lipocine Inc. (LPCN)vs › | $17.11M | N/A | 19.19x | 19.19x | 19.19x |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2025-10-20 | 2.49x |
| 2025-10-17 | 2.63x |
| 2025-10-16 | 2.24x |
| 2025-10-15 | 4.55x |
| 2025-10-14 | 3.22x |
| 2025-10-13 | 3.97x |
| 2025-10-10 | 4.84x |
| 2025-10-09 | 6.51x |
| 2025-10-08 | 5.81x |
| 2025-10-07 | 6.26x |
| 2025-10-06 | 7.63x |
| 2025-10-03 | 7.03x |
| 2025-10-02 | 1.65x |
| 2025-10-01 | 0.76x |
| 2025-09-29 | 752.88x |
| 2025-09-26 | 781.63x |
| 2025-09-25 | 790.57x |
| 2025-09-24 | 726.70x |
| 2025-09-23 | 700.51x |
| 2025-09-22 | 625.15x |
| 2025-09-19 | 640.47x |
| 2025-09-18 | 595.77x |
| 2025-09-17 | 674.33x |
| 2025-09-16 | 794.40x |
| 2025-09-15 | 766.30x |
| 2025-09-12 | 826.33x |
| 2025-09-11 | 888.93x |
| 2025-09-10 | 884.46x |
| 2025-09-09 | 959.82x |
| 2025-09-08 | 825.06x |
| 2025-09-05 | 754.80x |
| 2025-09-04 | 756.72x |
| 2025-09-03 | 825.70x |
| 2025-09-02 | 758.63x |
| 2025-08-29 | 719.03x |
| 2025-08-28 | 775.24x |
| 2025-08-27 | 648.14x |
| 2025-08-26 | 523.59x |
| 2025-08-25 | 464.20x |
| 2025-08-22 | 453.98x |
| 2025-08-21 | 437.37x |
| 2025-08-20 | 438.65x |
| 2025-08-19 | 483.36x |
| 2025-08-18 | 492.94x |
| 2025-08-15 | 512.74x |
| 2025-08-14 | 512.74x |
| 2025-08-13 | 503.16x |
| 2025-08-12 | 465.47x |
| 2025-08-11 | 455.25x |
| 2025-08-08 | 469.94x |
| 2025-08-07 | 490.38x |
| 2025-08-06 | 496.13x |
| 2025-08-05 | 480.16x |
| 2025-08-04 | 492.30x |
| 2025-08-01 | 509.54x |
| 2025-07-31 | 513.37x |
| 2025-07-30 | 516.57x |
| 2025-07-29 | 542.12x |
| 2025-07-28 | 550.42x |
| 2025-07-25 | 538.28x |
| 2025-07-24 | 531.90x |
| 2025-07-23 | 519.12x |
| 2025-07-22 | 487.19x |
| 2025-07-21 | 487.19x |
| 2025-07-18 | 471.22x |
| 2025-07-17 | 473.78x |
| 2025-07-16 | 471.86x |
| 2025-07-15 | 478.25x |
| 2025-07-14 | 487.19x |
| 2025-07-11 | 486.55x |
| 2025-07-10 | 480.80x |
| 2025-07-09 | 471.86x |
| 2025-07-08 | 455.25x |
| 2025-07-07 | 452.70x |
| 2025-07-03 | 450.78x |
| 2025-07-02 | 443.76x |
| 2025-07-01 | 443.76x |
| 2025-06-30 | 448.87x |
| 2025-06-27 | 442.48x |
| 2025-06-26 | 429.71x |
| 2025-06-25 | 442.48x |
| 2025-06-24 | 391.38x |
| 2025-06-23 | 381.80x |
| 2025-06-20 | 429.71x |
| 2025-06-18 | 418.21x |
| 2025-06-17 | 427.15x |
| 2025-06-16 | 423.32x |
| 2025-06-13 | 430.98x |
| 2025-06-12 | 451.42x |
| 2025-06-11 | 452.06x |
| 2025-06-10 | 453.98x |
| 2025-06-09 | 430.98x |
| 2025-06-06 | 434.18x |
| 2025-06-05 | 452.06x |
| 2025-06-04 | 452.06x |
| 2025-06-03 | 432.90x |
| 2025-06-02 | 443.12x |
| 2025-05-30 | 420.13x |
| 2025-05-29 | 409.27x |
| 2025-05-28 | 411.82x |
| 2025-05-27 | 425.87x |
| 2025-05-23 | 428.43x |
| 2025-05-22 | 393.30x |
| 2025-05-21 | 348.59x |
